|
|||||
|
|
A Phase I study of MEDI-575, a PDGFRα monoclonal antibody,in Japanese patients with advanced solid tumors |
|
| Authors: | Haruyasu Murakami Masafumi Ikeda Takuji Okusaka Yoshitaka Inaba Haruo Iguchi Katsuro Yagawa Nobuyuki Yamamoto |
| Affiliation: | 1. Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumicho Sunto-Gun, Shizuoka, 411-8777, Japan 2. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center East Hospital, Kashiwa, Chiba, Japan 3. Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan 4. Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan 5. Clinical Research Institute, Shikoku Cancer Center, Matsuyama City, Ehime, Japan 6. R&D, Clinical Science Department, AstraZeneca KK, Osaka, Japan 7. Third Department of Internal Medicine, Wakayama Medical University School of Medicine, Wakayama, Japan |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |
